Results 1 to 10 of about 97,441 (133)

The SARS-CoV-2 spike glycoprotein interacts with MAO-B and impairs mitochondrial energetics [PDF]

open access: yesCurrent Research in Neurobiology, 2023
SARS-CoV-2 infection is associated with both acute and post-acute neurological symptoms. Emerging evidence suggests that SARS-CoV-2 can alter mitochondrial metabolism, suggesting that changes in brain metabolism may contribute to the development of acute
Chantal A. Pileggi   +9 more
doaj   +2 more sources

Mechanistic insights into ligand dissociation from the SARS-CoV-2 spike glycoprotein. [PDF]

open access: yesPLoS Computational Biology
The COVID-19 pandemic, driven by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spurred an urgent need for effective therapeutic interventions.
Timothy Hasse   +6 more
doaj   +2 more sources

A bioinformatic analysis of the spike glycoprotein & evolution of COVID-19

open access: yesMedicine Science, 2022
The Severe Acute Respiratory Syndrome 2 (COVID-19/SARS-CoV-2) has become the pandemic of the century due to its drastically infectious nature. SARS & MERS are the most notable of past coronaviruses infecting merely thousands compared to COVID-19’s ...
Atiksh Chandra, Sathees B Chandra
doaj   +1 more source

The Characteristics of Spike Glycoprotein Gene of Swine Acute Diarrhea Syndrome Coronavirus Strain CH/FJWT/2018 Isolated in China

open access: yesFrontiers in Veterinary Science, 2021
Swine acute diarrhea syndrome (SADS) is a highly contagious infectious disease characterized by acute vomiting and watery diarrhea in neonatal piglets.
Yan-Yan Guo   +8 more
doaj   +1 more source

ACE2 overexpressing mesenchymal stem cells alleviates COVID-19 lung injury by inhibiting pyroptosis

open access: yesiScience, 2022
Summary: Mesenchymal stem cells (MSCs) have shown some efficacy in the COVID-19 treatment. We proposed that exogenous supplementation of ACE2 via MSCs (ACE2-MSCs) might have better therapeutic effects.
Jinhuan Wei   +7 more
doaj   +1 more source

SARS‐CoV‐2 spike glycoprotein‐reactive T cells can be readily expanded from COVID‐19 vaccinated donors

open access: yesImmunity, Inflammation and Disease, 2021
Introduction The COVID‐19 vaccine was designed to provide protection against infection by the severe respiratory coronavirus 2 (SARS‐CoV‐2) and coronavirus disease 2019 (COVID‐19).
Pavla Taborska   +5 more
doaj   +1 more source

The screening and evaluation of potential clinically significant HIV drug combinations against the SARS-CoV-2 virus

open access: yesInformatics in Medicine Unlocked, 2021
Spike glycoprotein is essential for the reproduction of the SARS-CoV-2 virus, and its inhibition using already approved antiviral drugs may open new avenues for treatment of patients with the COVID-19 disease.
Draško Tomić   +13 more
doaj   +1 more source

In silico Identification of Characteristics Spike Glycoprotein of SARS-CoV-2 in the Development Novel Candidates for COVID-19 Infectious Diseases

open access: yesJournal of Biomedicine and Translational Research, 2020
Background: The emergence of infectious diseases caused by SARS-CoV-2 has resulted in more than 90,000 infections and 3,000 deaths. The coronavirus spike glycoprotein encourages the entry of SARS-CoV-2 into cells and is the main target of antivirals ...
Taufik Muhammad Fakih   +1 more
doaj   +1 more source

Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses in vivo and Inhibit Viral Replication in vitro

open access: yesFrontiers in Immunology, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) initiates infection by attachment of the surface-exposed spike glycoprotein to the host cell receptors.
Preeti Vishwakarma   +12 more
doaj   +1 more source

Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response

open access: yesBMJ Open Respiratory Research, 2021
Objective To determine clinical and ethnodemographic correlates of serological responses against the SARS-CoV-2 spike glycoprotein following mild-to-moderate COVID-19.Design A retrospective cohort study of healthcare workers who had self-isolated due to ...
Saly Al-Taei   +20 more
doaj   +1 more source

Home - About - Disclaimer - Privacy